SCHEDULE: Atlas Venture Divests Entire Stake in Integral Ad Science
Beneficial Ownership Amendment
Atlas Venture entities have reported a 0.0% beneficial ownership in Integral Ad Science Holding Corp., indicating a full divestment of their previous stake.
Summary
- Atlas Venture Fund VIII, L.P., Atlas Venture Associates VIII, L.P., and Atlas Venture Associates VIII, Inc. (collectively, the "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G.
- As of December 23, 2025, the Reporting Persons beneficially own 0.00 shares of Common Stock of Integral Ad Science Holding Corp.
- This represents 0.0% of the class of Common Stock.
- The Reporting Persons hold no sole or shared voting power, nor sole or shared dispositive power over any shares of Integral Ad Science Holding Corp.
Sentiment
Score: 5
Explanation: The filing is a factual report of a change in beneficial ownership, specifically a complete divestment. It does not contain qualitative statements or financial performance data to indicate a positive or negative sentiment from the perspective of the filing itself.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Integral Ad Science Holding Corp.'s future performance or operations.
Industry Context
This filing reflects a specific ownership change by a venture capital firm in a publicly traded ad tech company. It does not provide broader industry trends or competitive analysis, but a significant divestment by an early investor could be interpreted in various ways by the market regarding the company's future prospects or the investor's portfolio strategy.
Stakeholder Impact
- Shareholders of Integral Ad Science Holding Corp. may view the complete divestment by Atlas Venture as a signal, potentially influencing their perception of the company's long-term value or future growth prospects.
Key Dates
| Date | Description |
|---|---|
| 12/23/2025 | Date of event which requires filing of this statement, indicating the date beneficial ownership dropped to 0.0%. |
| 12/23/2025 | Date the Schedule 13G Amendment No. 2 was signed by Atlas Venture. |
Keywords
Integral Ad Science, Atlas Venture, Schedule 13G, beneficial ownership, divestment, common stock, institutional investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.